KU14R

CAS: 189224-48-4

Ref. 3D-PHA22448

Produktinformation

• Name: KU14R
• Marke: Biosynth
• Beschreibung: KU14R is a novel molecule that can be used as a pharmacological agent to treat diabetes. It blocks the ATP-sensitive potassium channels in the hippocampus, which leads to an increase in cytosolic calcium levels and inhibits beta-cell function. KU14R also blocks the ATP-sensitive potassium channels in the bladder, which results in increased camp levels and pge2 levels. This drug has been shown to have a beneficial effect on diabetic patients. The molecular targets of KU14R are intracellular targets including transcription-polymerase chain and protein synthesis. KU14R also inhibits potassium channel activity by blocking voltage-gated potassium channels, leading to an increase in cytosolic calcium levels and inhibition of beta-cell function.

Chemische Eigenschaften

• Molekulargewicht: 214.27 g/mol
• Formel: C₁₃H₁₄N₂O
• Reinheit: Min. 95%